Prostate cancer is the second most common cancer in men worldwide. The PCCTC and Movember Foundation are working to halve the number of deaths from prostate cancer by 2030.
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.